Physician

David Galetto, MD

According to 2025 Medicare claims, David Galetto, MD (NPI: 1871574962) practices internal medicine in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CUMBERLAND INTERNAL MEDICINE (NPI: 1881618932; TIN: 223053211) and primary practice location at 08361-8469. Galetto is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Galetto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 717 traditional Medicare patients, billed 2,243 HCPCS/CPT codes, and received $171,709 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,195 prescription claims across 566 beneficiaries totaling $289,486 in drug costs, led by Jardiance (Empagliflozin). DME data shows 19 claims. Open Payments data shows 3 records totaling $54. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,079 and ending at $24,524.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	947	22,808	$253,120
2016	940	10,548	$237,991
2017	944	4,872	$220,820
2018	805	4,310	$208,187
2019	788	3,770	$194,146
2020	892	3,495	$189,643
2021	818	2,621	$170,835
2022	725	2,495	$175,607
2023	744	2,850	$203,314
2024	717	2,243	$171,709

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	437	5,508	$439,039
2016	466	5,950	$467,652
2017	461	5,905	$467,794
2018	452	5,919	$444,343
2019	493	6,028	$400,582
2020	569	5,314	$359,082
2021	550	4,522	$363,168
2022	546	4,700	$347,506
2023	532	4,881	$367,506
2024	566	5,195	$289,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	69	217	$5,889
2016	63	202	$4,620
2017	24	89	$1,577
2018	32	115	$1,914
2019	29	132	$1,801
2020	15	137	$5,568
2021	14	128	$5,283
2022	N/R	60	$1,933
2023	11	57	$3,970
2024	N/R	19	$345

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	110	110	$137
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	140	145	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	213	368	$100
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	280	467	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	172	238	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	17	1,440	$26,524
Eliquis	Apixaban	26	1,380	$25,206
Januvia	Sitagliptin Phosphate	14	1,200	$20,811
Ozempic	Semaglutide	16	616	$18,758
Breo Ellipta	Fluticasone/Vilanterol	11	570	$7,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	19	$345

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$54	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Galetto, MD?

Tedicare shows public-source Medicare data for David Galetto, MD (NPI 1871574962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Galetto, MD have ACO affiliation data?

David Galetto, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to David Galetto, MD?

David Galetto, MD is linked to CUMBERLAND INTERNAL MEDICINE (billing NPI 1881618932) in the available physician profile data.

Does David Galetto, MD have Open Payments data?

David Galetto, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.